Literature DB >> 18998741

Pharmacotherapy of essential tremor : an overview of existing and upcoming agents.

Kelly E Lyons1, Rajesh Pahwa.   

Abstract

Essential tremor is one of the most common movement disorders, yet the pharmacological treatments currently available have limited efficacy, being effective in only approximately 50% of patients with this disorder. The most commonly used, and generally most effective, medications for essential tremor are propranolol and primidone, administered either as monotherapy or in combination. If these medications do not provide satisfactory control of tremor, other beta-adrenoceptor antagonists, such as metoprolol or atenolol, and other antiepileptic drugs, such as topiramate or gabapentin, are often tried. In addition, benzodiazepines can be effective in some patients, particularly those with associated anxiety. There is a need for additional medications that result in greater tremor control in a larger number of patients with essential tremor. Several new drugs, including 1-octanol, sodium oxybate, dimethoxymethyl-diphenyl-barbituric acid (T-2000) and carisbamate, are currently under investigation for the treatment of essential tremor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18998741     DOI: 10.2165/0023210-200822120-00006

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  69 in total

1.  Treatment of essential tremor with arotinolol.

Authors:  Y Kuroda; R Kakigi; H Shibasaki
Journal:  Neurology       Date:  1988-04       Impact factor: 9.910

2.  beta-Adrenoreceptor antagonists in essential tremor.

Authors:  D Jefferson; P Jenner; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-10       Impact factor: 10.154

Review 3.  Carisbamate (RWJ-333369).

Authors:  Gerald P Novak; Michael Kelley; Peter Zannikos; Brian Klein
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

4.  A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.

Authors:  Theresa A Zesiewicz; Christopher L Ward; Robert A Hauser; Juan Sanchez-Ramos; Joseph F Staffetti; Kelly L Sullivan
Journal:  Mov Disord       Date:  2007-01-15       Impact factor: 10.338

5.  Bilateral thalamic deep brain stimulation: midline tremor control.

Authors:  J D Putzke; R J Uitti; A A Obwegeser; Z K Wszolek; R E Wharen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

6.  Differential selectivity of several barbiturates on experimental seizures and neurotoxicity in the mouse.

Authors:  A Raines; G J Blake; B Richardson; M B Gilbert
Journal:  Epilepsia       Date:  1979-04       Impact factor: 5.864

7.  Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial.

Authors:  W Ondo; C Hunter; K D Vuong; K Schwartz; J Jankovic
Journal:  Mov Disord       Date:  2000-07       Impact factor: 10.338

8.  Effect of alcohol on tremors: comparison with propranolol.

Authors:  W C Koller; N Biary
Journal:  Neurology       Date:  1984-02       Impact factor: 9.910

9.  Levetiracetam is not effective for essential tremor.

Authors:  Rodger J Elble; Kelly E Lyons; Rajesh Pahwa
Journal:  Clin Neuropharmacol       Date:  2007 Nov-Dec       Impact factor: 1.592

10.  Primidone and propranolol in essential tremor: a study based on quantitative tremor recording and plasma anticonvulsant levels.

Authors:  P Dietrichson; E Espen
Journal:  Acta Neurol Scand       Date:  1987-05       Impact factor: 3.209

View more
  13 in total

1.  L-type calcium channel blockers and Parkinson disease in Denmark.

Authors:  Beate Ritz; Shannon L Rhodes; Lei Qian; Eva Schernhammer; Jørgen H Olsen; Søren Friis
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

2.  Pharmacologic management of essential tremor.

Authors:  Mark Lees; Loren Regier; Brent Jensen
Journal:  Can Fam Physician       Date:  2010-03       Impact factor: 3.275

Review 3.  Diagnosis and treatment of common forms of tremor.

Authors:  Andreas Puschmann; Zbigniew K Wszolek
Journal:  Semin Neurol       Date:  2011-02-14       Impact factor: 3.420

Review 4.  An update on essential tremor.

Authors:  Rodger J Elble; Günther Deuschl
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

5.  β-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study.

Authors:  Kasper Meidahl Petersen; Espen Jimenez-Solem; Jon Traerup Andersen; Morten Petersen; Kasper Brødbæk; Lars Køber; Christian Torp-Pedersen; Henrik Enghusen Poulsen
Journal:  BMJ Open       Date:  2012-07-19       Impact factor: 2.692

6.  Illicit stimulant use in humans is associated with a long-term increase in tremor.

Authors:  Stanley C Flavel; Jenna D Koch; Jason M White; Gabrielle Todd
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

7.  Use of antiepileptic drugs for hyperkinetic movement disorders.

Authors:  A Siniscalchi; L Gallelli; G De Sarro
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

8.  Treatment of Essential Tremor: Are there Issues We are Overlooking?

Authors:  Elan D Louis
Journal:  Front Neurol       Date:  2012-01-13       Impact factor: 4.003

Review 9.  Closed-loop brain-machine-body interfaces for noninvasive rehabilitation of movement disorders.

Authors:  Frédéric D Broccard; Tim Mullen; Yu Mike Chi; David Peterson; John R Iversen; Mike Arnold; Kenneth Kreutz-Delgado; Tzyy-Ping Jung; Scott Makeig; Howard Poizner; Terrence Sejnowski; Gert Cauwenberghs
Journal:  Ann Biomed Eng       Date:  2014-05-15       Impact factor: 3.934

10.  Sustained Medication Reduction Following Unilateral VIM Thalamic Stimulation for Essential Tremor.

Authors:  Andrew S Resnick; Michael S Okun; Teresita Malapira; Donald Smith; Fernando L Vale; Kelly Sullivan; Amber Miller; Israt Jahan; Theresa Zesiewicz
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.